GSE77108 saha 5 v 7 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE77108_saha_5_v_7_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE77108_saha_5_v_7_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE77108_saha_5_v_7_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE77108_saha_5_v_7_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

long intergenic non-protein coding RNA 1291

Gene

protein kinase Y-linked (pseudogene)

Gene

MIR34A host gene

Gene

mitotically associated long non coding RNA

Gene

PPP3CB antisense RNA 1

Gene

GTPase, very large interferon inducible pseudogene 1

Gene

long intergenic non-protein coding RNA 1091

Gene

CARD8 antisense RNA 1

Gene

long intergenic non-protein coding RNA 3140

Gene

DEAD/H-box helicase 11 like 2 (pseudogene)

  • Gene

    long intergenic non-protein coding RNA 1291


  • Gene

    protein kinase Y-linked (pseudogene)



  • Gene

    mitotically associated long non coding RNA


  • Gene

    PPP3CB antisense RNA 1


  • Gene

    GTPase, very large interferon inducible pseudogene 1


  • Gene

    long intergenic non-protein coding RNA 1091


  • Gene

    CARD8 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 3140


  • Gene

    DEAD/H-box helicase 11 like 2 (pseudogene)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.